Loading...
XJPX
6849
Market cap1.48bUSD
Jul 10, Last price  
1,499.50JPY
1D
-0.03%
1Q
-2.09%
Jan 2017
-42.04%
Name

Nihon Kohden Corp

Chart & Performance

D1W1MN
XJPX:6849 chart
P/E
15.59
P/S
0.96
EPS
96.20
Div Yield, %
2.13%
Shrs. gr., 5y
-0.65%
Rev. gr., 5y
4.53%
Revenues
249.28b
+10.58%
96,679,000,000104,825,000,000109,123,000,000107,013,000,000113,380,000,000120,718,000,000132,538,000,000153,194,000,000160,803,000,000165,522,000,000166,285,000,000174,249,000,000178,799,000,000185,007,000,000199,727,000,000205,129,000,000206,603,000,000221,986,000,000225,424,000,000249,277,314,154
Net income
15.39b
+9.16%
5,052,000,0005,631,000,0004,610,000,0005,917,000,0006,573,000,0007,621,000,0009,151,000,00012,346,000,00011,142,000,00010,516,000,0009,149,000,0009,154,000,00011,191,000,0009,854,000,00018,243,000,00023,435,000,00017,110,000,00017,026,000,00014,098,000,00015,389,308,006
CFO
22.32b
+46.05%
5,882,000,0008,621,000,0004,123,000,00010,679,000,0005,892,000,0007,559,000,00013,189,000,0009,383,000,00012,505,000,00010,765,000,00011,356,000,00010,843,000,0009,819,000,0009,217,000,00013,945,000,00025,699,000,000-2,513,000,00015,607,000,00015,286,000,00022,324,782,000
Dividend
Sep 29, 202616 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nihon Kohden Corporation, founded in 1951 and headquartered in Tokyo, Japan, is a global leader in healthcare technology. The company’s core operations encompass the research, development, manufacturing, sales, repair, and maintenance of advanced medical electronic equipment, serving markets across Japan, the Americas, Europe, Asia, and other international regions. Its extensive product range features sophisticated physiological measurement instruments, including electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram (EMG) systems, and polygraphs for cardiac catheterization laboratories. These offerings are integrated with diagnostic information systems and supported by essential consumables like recording papers, electrodes, and catheters, along with comprehensive maintenance services. Nihon Kohden also delivers cutting-edge patient monitoring solutions, such as central, bedside, and wireless monitors, alongside remote access software. These are seamlessly linked with clinical information systems and provided with associated disposables, including various electrodes and sensors. The company's therapeutic device portfolio includes critical equipment like defibrillators (including automated external defibrillators or AEDs), ventilators, pacemakers, anesthesia machines, and cochlear implants. Necessary consumables, such as AED pads and batteries, and related services are also supplied for these products. Furthermore, Nihon Kohden offers other specialized medical apparatus, such as hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and tools for research purposes. These are accompanied by consumables like test reagents, installation services, and ongoing maintenance. Beyond its primary focus on medical devices, the corporation also participates in insurance brokerage and technology licensing.
IPO date
Nov 02, 1961
Employees
5,751
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT